Fortis may be out of F&O if results delayed

The National Stock Exchange of India on Thursday said it will exclude Fortis Healthcare from the derivatives segment if the company fails to submit its financial results for the September and December quarter by March 1, reports Our Bureau.

So far, Fortis Healthcare has failed to submit its quarterly financial results for the September and December quarter, said NSE. Fortis has intimated to exchanges that its board will consider results for the two quarters in meeting on February 28.

  • Related Posts

    Lilly launches Mounjaro KwikPen in India

    Mumbai, August 14, 2025 — Eli Lilly and Company (India) has rolled out the Mounjaro (tirzepatide) KwikPen across the country, expanding treatment choices for people with type-2 diabetes and those…

    Fortis Q1 Profit Jumps 57%; Expansion Drives Growth

      Gurugram, August 7 – http://Fortis HealthcareFortis Healthcare has reported a 57% year-on-year increase in its net profit for the first quarter of FY2025. The hospital chain posted ₹260 crore…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Alembic Pharma Gets USFDA Nod for Dapagliflozin

    Alembic Pharma Gets USFDA Nod for Dapagliflozin

    On World Health Day ‘CAHO Na Patient Se Pyaar Hai’

    On World Health Day ‘CAHO Na Patient Se Pyaar Hai’

    Supreme Court willing to understand Angst of Doctors regarding Consumer Protection Act

    Supreme Court willing to understand Angst of Doctors regarding Consumer Protection Act

    Aurobindo Pharma Board approves ₹800 cr share buyback plan

    Aurobindo Pharma Board approves ₹800 cr share buyback plan

    Three held for cheating SCB Hospital patients on promise of arranging blood

    Three held for cheating SCB Hospital patients on promise of arranging blood

    NATHEALTH resolves to evolve to fit The Bill of Viksit Bharat

    NATHEALTH   resolves to evolve to fit The Bill of Viksit Bharat